Re-establishing miR-146a expression within breast cancer has been shown to decrease the levels of immunostimulatory genes and to antagonize NF-kB signaling, reducing cancer cell migration and metastatic mechanisms [185, 187]. This evidence concerns the gene NFKB1 and breast carcinoma.